sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastična sredstva - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
zaltrap
sanofi winthrop industrie - aflibercept - kolorektalne neoplazme - antineoplastična sredstva - zdravljenje metastatskega kolorektalnega raka (mcrc).
lusmose 50 mg trde kapsule
sunitinib - kapsula, trda - sunitinib 50 mg / 1 kapsula - sunitinib
glimepirid lek 3 mg tablete
lek d.d. - glimepirid - tableta - glimepirid 3 mg / 1 tableta - glimepirid
glimepirid lek 1 mg tablete
lek d.d. - glimepirid - tableta - glimepirid 1 mg / 1 tableta - glimepirid
glimepirid lek 1 mg tablete
lek d.d. - glimepirid - tableta - glimepirid 1 mg / 1 tableta - glimepirid
glimepirid lek 2 mg tablete
lek d.d. - glimepirid - tableta - glimepirid 2 mg / 1 tableta - glimepirid
glimepirid lek 2 mg tablete
lek d.d. - glimepirid - tableta - glimepirid 2 mg / 1 tableta - glimepirid
glimepirid lek 4 mg tablete
lek d.d. - glimepirid - tableta - glimepirid 4 mg / 1 tableta - glimepirid
glimepirid lek 4 mg tablete
lek d.d. - glimepirid - tableta - glimepirid 4 mg / 1 tableta - glimepirid